Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment